All In Biotech

Drug Trial Radar · NCT05503797

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

A Phase 2 Master Protocol to Assess the Efficacy and Safety of FORE8394, an Inhibitor of BRAF Class 1 and Class 2 Alterations, in Participants With Cancer Harboring BRAF Alterations

Last checked: Nov 20, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

254

Planned (sponsor's estimate)

Start

Feb 21, 2023

Primary completion

Dec 31, 2027

Study completion Dec 28, 2028

Sponsor

Lead sponsor
Fore BiotherapeuticsIndustry
Sponsor type
Industry
First posted
Aug 17, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 8 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with BRAF altered (BRAF V600E or BRAF fusions) locally advanced or metastatic solid tumors, or recurrent or progressive primary central nervous system (CNS) tumors, including rare BRAF V600E-mutated solid tumors, including anaplastic thyroid, ovarian, cholangiocarcinoma or other rare cancers.

Conditions

  • Cancer Harboring BRAF Alterations
  • HGG
  • LGG
  • Solid Tumors

Interventions

  • PlixorafenibDrug

    Oral tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate (ORR) (Subprotocols A, B and C)Time frame: Up to approximately 4 years
  2. Pharmacokinetics (Subprotocol D)Time frame: Up to approximately 4 years

Locations

70 sites in 12 countries. Site status is shown where the registry gives one.

  • Precision NextGen Oncology & Research Center

    Beverly Hills, California · Recruiting

  • UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, California · Recruiting

  • University of California Los Angeles Rheumatology

    Westwood, Los Angeles, California · Recruiting

  • Norwalk Hospital

    Norwalk, Connecticut · Recruiting

  • University of Miami Hospital and Clinics

    Miami, Florida · Recruiting

  • The John Hopkins Hospital

    Baltimore, Maryland · Recruiting

  • Maryland Oncology Hematology- Columbia

    Rockville, Maryland · Recruiting

  • Tufts Medical Center

    Boston, Massachusetts · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Not yet recruiting

  • St. Luke's Hospital

    Duluth, Minnesota · Recruiting

  • Mosaic Life Care at Saint Joseph - Medical Center

    Saint Joseph, Missouri · Recruiting

  • Nebraska Cancer Specialists - Midwest Cancer Center - Legacy

    Omaha, Nebraska · Recruiting

  • Overlook Medical Center

    Summit, New Jersey · Recruiting

  • Columbia University Irving Medical Center

    New York, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • Atrium Health Wake Forest Baptist - Comprehensive Cancer Center

    Winston-Salem, North Carolina · Recruiting

  • Nationwide Children's Hospital

    Colombus, Ohio · Recruiting

  • The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute

    Columbus, Ohio · Recruiting

  • Taylor Cancer Research Center

    Maumee, Ohio · Recruiting

  • Toledo Clinic Cancer Center

    Toledo, Ohio · Completed

  • Thomas Jefferson University

    Philadelphia, Pennsylvania · Recruiting

  • Lifespan Cancer Institute - Rhode Island Hospital

    Providence, Rhode Island · Recruiting

  • SCRI - TriStar Medical Group Children's Specialists

    Nashville, Tennessee · Recruiting

  • SCRI Oncology Partners

    Nashville, Tennessee · Recruiting

  • Baylor Scott & White Research Institute

    Dallas, Texas · Recruiting

  • University of Texas MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • Baylor Scott & White Medical Center

    Temple, Texas · Recruiting

  • University of Washington School of Medicine

    Seattle, Washington · Recruiting

  • West Virginia University Health Sciences Campus

    Morgantown, West Virginia · Recruiting

  • Newcastle Private Hospital

    New Lambton Heights, New South Wales, Australia · Recruiting

  • Orange Health Service

    Orange, New South Wales, Australia · Recruiting

  • Sydney Children's Hospital Network - Randwick

    Randwick, New South Wales, Australia · Recruiting

  • Flinders Medical Centre

    Bedford Park, South Australia, Australia · Recruiting

  • The Alfred

    Melbourne, Victoria, Australia · Recruiting

  • Sunny brook Health Sciences Centre- Bayview Campus

    Toronto, Ontario, Canada · Recruiting

  • Centre Hospitalier Universitaire Sainte-Justine

    Montreal, Quebec, Canada · Recruiting

  • Institut Universitaire du Cancer de Toulouse Oncopole

    Toulouse, France · Recruiting

  • Institut Bergonie

    Bordeaux, Aquitaine, France · Recruiting

  • Hôpital Nord de Marseille

    Marseille, Bouches-du-Rhône, France · Recruiting

Showing 40 of 70 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.